The effect of fluvastatin on plasma adiponectin levels in dyslipidaemia

Clinical Endocrinology
Alper SonmezSelahattin Erikci

Abstract

There is controversy about the effects of statins on insulin resistance and plasma adiponectin. The aim of this study was to investigate the effects of fluvastatin treatment on these parameters in a group of dyslipidaemic patients who had no confounding factors for insulin resistance or alterations in plasma adiponectin. Forty-nine patients [27 males, 22 females; mean age 47.2 +/- 10.3 years; body mass index (BMI) 29.64 +/- 3.2 kg/m2] with dyslipidaemia and 20 controls (six males, 14 females; mean age 45.3 +/- 9.31 years; BMI 30.07 +/- 4.04 kg/m2) were enrolled. All patients were treated initially with therapeutic lifestyle changes (TLC) for 6 weeks. Six out of 49 subjects were excluded from the study. Then, 24 out of 43 patients with high blood cholesterol despite TLC were allocated to fluvastatin 80 mg daily plus TLC, and the remaining 19 patients with normal cholesterol were subjected to TLC alone for additional 12 weeks. Plasma adiponectin, immunoreactive insulin levels, BMI, waist circumference, blood pressure, lipids, and glucose were determined. The insulin sensitivity index was quantified using the homeostasis model assessment (HOMA). TLC caused significant improvement in plasma insulin (P = 0.02) and elevation in plasm...Continue Reading

References

Apr 11, 1996·The New England Journal of Medicine·J P DesprésP J Lupien
Apr 16, 1996·Biochemical and Biophysical Research Communications·K MaedaK Matsubara
May 23, 2001·JAMA : the Journal of the American Medical Association·UNKNOWN Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
Feb 7, 2002·JAMA : the Journal of the American Medical Association·Antti JulaTapani Rönnemaa
Mar 30, 2002·The Journal of International Medical Research·B Y CingözbayM E Onde
Jan 14, 2003·Arteriosclerosis, Thrombosis, and Vascular Biology·Masahiro KumadaUNKNOWN Osaka CAD Study Group. Coronary artery disease
Mar 7, 2003·Journal of Atherosclerosis and Thrombosis·Tadashi YamakawaKenji Okuda
Apr 10, 2003·JAMA : the Journal of the American Medical Association·Katherine EspositoDario Giugliano
Sep 16, 2003·Obesity Research·Lais U MonzilloChristos S Mantzoros
Feb 12, 2004·The Medical Clinics of North America·James R Sowers, Edward D Frohlich
Apr 10, 2004·Biological Trace Element Research·M Ilker YilmazI Hakki Kocar
Apr 15, 2004·JAMA : the Journal of the American Medical Association·Tobias PischonEric B Rimm
Nov 9, 2004·Atherosclerosis. Supplements·T R PedersenUNKNOWN Scandinavian Simvastatin Survival Study Group
Jan 20, 2005·Journal of Internal Medicine·M E Trujillo, P E Scherer
Feb 25, 2005·Current Atherosclerosis Reports·Allison M PritchettDouglas L Mann
Apr 30, 2005·Seminars in Vascular Medicine·Sabine Steffens, Francois Mach
May 17, 2005·Journal of the American College of Cardiology·Kwang Kon KohEak Kyun Shin
Jul 1, 2005·Metabolism: Clinical and Experimental·Marie-Hélène Gannagé-YaredGeorges Halaby
Jul 12, 2005·Endocrine Journal·Chie OhmuraRyuzo Kawamori
Nov 10, 2005·The Clinical Biochemist. Reviews·Gisela Wilcox

❮ Previous
Next ❯

Citations

May 4, 2011·World Journal of Diabetes·Desiree WandersRobert L Judd
Oct 3, 2007·Internal and Emergency Medicine·R TarquiniG F Gensini
Feb 13, 2009·Current Medical Research and Opinion·M van HoekG M Dallinga-Thie
May 16, 2009·Journal of the Formosan Medical Association = Taiwan Yi Zhi·Lin-Chau ChangWei-Shiung Yang
Jan 1, 2014·Diabetes, Obesity & Metabolism·D S H BellJ H O'Keefe
Oct 24, 2007·The American Journal of Cardiology·Sridevi DevarajIshwarlal Jialal
Jan 13, 2015·Atherosclerosis. Supplements·Lorenzo Arnaboldi, Alberto Corsini
Nov 16, 2014·Current Atherosclerosis Reports·Dick C ChanGerald F Watts
Mar 7, 2018·The Cochrane Database of Systematic Reviews·Stephen P AdamsJames M Wright
May 15, 2007·Current Opinion in Lipidology·Cristina Lara-CastroW Timothy Garvey
Dec 16, 2020·Diabetes, Obesity & Metabolism·David S H Bell, Edison Goncalves

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.